OUR STORY

Europe's Leading Healthcare Evidence, Pricing and Access Congress

The World Evidence, Pricing and Access Congress 2026 returns as Europe's largest meeting point for global leaders in pharma, biotech, and HTA. With over 1,500 attendees, 250 expert speakers, and 10 focused content tracks , it is the must-attend event for anyone working at the intersection of access, pricing, and real-world evidence.
 
Join industry leaders from top 50 pharma companies including Novartis, Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Pfizer, and Merck, who will take the stage to share cutting-edge strategies in pricing, market access and value demonstration . From the future of sustainable access to innovative payment models, our sessions will explore the most pressing challenges in the field.
 
We are proud to partner with leading solution providers including ZS, Parexel, Lifescience Dynamics, Valid Insight, Genesis Research, Partners4Access and more who will be showcasing cutting edge the tools and strategies shaping the future of access.